Award
National Cancer Institute PAR-24-085
Optimization of an active mutant KRAS peptide vaccine in colorectal cancer
Recipient
Johns Hopkins University
Awarded
January 16, 2026
Identifier
PAR-24-085
NIH grant awarded to Johns Hopkins University for research on KRAS peptide vaccine optimization in colorectal cancer, focusing on clinical and preclinical studies.
Description
This NIH grant supports research on KRAS-targeted vaccines and immunotherapy for colorectal cancer, including clinical trials and preclinical studies. The project involves multiple aims including clinical response evaluation, immunogenicity, and combination therapies with immune checkpoint inhibitors and KRAS signaling inhibitors.